Past Events by Category
Philip Chen Lecture: Using Water Migration to Probe Brain Structure and Architecture
Friday, April 29, 2022
Peter Basser, Ph.D., Senior Investigator, Quantitative Imaging and Tissue Sciences, Associate Scientific Director, Division of Imaging, Behavior and Genomic Integrity, NICHD, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Philip S. Chen Lecture: The Long and Winding Road Toward Molecular Cures of the First Molecular Disease
Friday, November 8, 2019
John Tisdale, M.D., Senior Investigator, Chief, Cellular and Molecular Therapeutics Branch, NHLBI, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Lightning Chess: How Host Immunity Gains a Winning Position Against Ebolavirus Infection
Friday, November 2, 2018
Nancy Sullivan, Ph.D., Senior Investigator, Section Chief, Biodefense Research Section, Vaccine Research Center, NIAID, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Cells as Anti-Cancer Drugs: Entering Mainstream Oncology
Friday, November 17, 2017
Steven A. Rosenberg, M.D., Ph.D., Branch Chief, Senior Investigator, Surgery Branch, National Cancer Institute, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Cytokine Signaling: Genes, Genomes and Drugs
Friday, October 14, 2016
John J. O'Shea, M.D., Scientific Director and Senior Investigator, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Unexpected Results from Unconventional Approaches to Adeno-associated Virus Research
Friday, October 23, 2015
Dr. Robert Kotin, Voyager Therapeutics and University of Massachusetts Medical School in Worcester
Category: Philip S. Chen - Innovation & Technology Transfer
Purine Receptor Drugs: Future Treatment for Chronic Diseases?
Friday, October 3, 2014
Kenneth A. Jacobson, Ph.D., Chief, Laboratory of Bioorganic Chemistry & Molecular Recognition Section, NIDDK, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
TB: It Takes More than a Village to Raise a Remedy
Friday, November 22, 2013
Dr. Clifton E. Barry, NIAID, NIH and Dr. Carol A. Nacy, Sequella, Inc.
Category: Philip S. Chen - Innovation & Technology Transfer
387 views - Runtime: 01:14:51
A Multifunctional Basement Matrix for Normal, Cancer, and Stem Cells: the BME/Matrigel Story
Thursday, November 15, 2012
Dr. Hynda Kleinman, NIDCR, NIH
Category: Philip S. Chen - Innovation & Technology Transfer
Treatment of Cancer with Recombinant Immunotoxins: from Technology Transfer to the Patient
Friday, December 9, 2011
Ira Pastan, M.D.
Category: Philip S. Chen - Innovation & Technology Transfer